Manufacturer
GlaxoSmithKline LLC
14 drugs, 55 product strengths, 20 recalls on record.
Drugs GlaxoSmithKline LLC makes
AdvairNo changeBrand · fluticasone / salmeterolPharmacies pay from$149Being discontinuedVentolinNo changeBrand · albuterolNo weekly price2 open recallsWellbutrin+0.1%Brand · bupropionPharmacies pay from$212ValtrexNo changeBrand · valacyclovirPharmacies pay from$384LamictalNo changeBrand · lamotriginePharmacies pay from$308Being discontinuedArnuityNo changeBrand · fluticasonePharmacies pay from$93.13BreoNo changeBrand · fluticasone / vilanterolPharmacies pay from$74.91Medicare price 2027Trelegy+0.1%Brand · fluticasone / umeclidinium / vilanterolPharmacies pay from$155Medicare price 2027Imitrex-0.1%Brand · sumatriptanPharmacies pay from$2,171Anoro+0.1%Brand · umeclidinium / vilanterolPharmacies pay from$56.23Medicare price 2028IncruseNo changeBrand · umeclidiniumPharmacies pay from$10.27Blujepa-0.2%Brand · gepotidacinPharmacies pay from$2,738SereventNo changeBrand · salmeterolPharmacies pay from$405RelenzaBrand · zanamivirNo weekly price
Recalls
Class IIITerminatedJun 12, 2024Tivicay PDLabeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle...GlaxoSmithKline LLC · D-0544-2024Class IIITerminatedJan 3, 2024ANORO ELLIPTAFailed Release Testing: Coarse Particle Mass for umeclidinium Out of SpecificationGlaxoSmithKline LLC · D-0160-2024Class IIITerminatedJun 1, 2022TivicayLabeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027...GlaxoSmithKline LLC · D-0896-2022Class IIOngoingMay 31, 2017Ventolin HFADefective Delivery System: Elevated number of units with out of specification results for leak rateGlaxoSmithKline, LLC · D-0793-2017Class IIOngoingApr 12, 2017Ventolin HFADefective Delivery System: Elevated number of units with out of specification results for leak rate.GlaxoSmithKline, LLC · D-0626-2017Class IITerminatedJul 27, 2016Bactroban CreamPenicillin Cross ContaminationGlaxoSmithKline, LLC · D-1442-2016Class IITerminatedJul 27, 2016Bactroban CreamPenicillin Cross ContaminationGlaxoSmithKline, LLC · D-1443-2016Class IITerminatedJul 27, 2016Bactroban NasalPenicillin Cross ContaminationGlaxoSmithKline, LLC · D-1444-2016Class IITerminatedJul 27, 2016Bactroban OintmentPenicillin Cross ContaminationGlaxoSmithKline, LLC · D-1445-2016Class IITerminatedDec 16, 2015Ventolin HFADefective Delivery System: Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.GlaxoSmithKline, LLC · D-0519-2016Class IITerminatedSep 2, 2015BactrobanPenicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.GlaxoSmithKline, LLC. · D-1359-2015Class IITerminatedSep 2, 2015Bactroban OintmentPenicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.GlaxoSmithKline, LLC. · D-1360-2015Class IITerminatedSep 2, 2015Bactroban CreamPenicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.GlaxoSmithKline, LLC. · D-1361-2015Class IITerminatedSep 2, 2015Mupirocin Calcium CreamPenicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.GlaxoSmithKline, LLC. · D-1362-2015Class IITerminatedJan 1, 2014Imitrex STATdose SystemLack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.GlaxoSmithKline, LLC. · D-387-2014Class IITerminatedJan 1, 2014Sumatriptan Succinate InjectionLack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.GlaxoSmithKline, LLC. · D-388-2014Class IIITerminatedAug 14, 2013TUMS, Antacid/Calcium SupplementPresence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tabletsGlaxoSmithKline, LLC. · D-850-2013Class IIITerminatedDec 5, 2012Advair HFAProduct Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.GlaxoSmithKline, LLC. · D-064-2013Class IIITerminatedDec 5, 2012Advair HFAProduct Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.GlaxoSmithKline, LLC. · D-065-2013Class IITerminatedDec 5, 2012ArranonImpurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.GlaxoSmithKline, LLC. · D-068-2013
About GlaxoSmithKline LLC
No comments yet. Questions, tips, what worked for you - start the conversation.